Purchases and Sales Made in Q1 2023 in Fulcrum Therapeutics, Inc. (FULC)
This table provides information about the institutional ownership of Fulcrum Therapeutics, Inc. (FULC) during Q1 2023. The information is specifically focused on institutions that hold shares of Fulcrum Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2023
Q1 2023
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-43K- 50.88% |
$122K - $602K
|
41.5K
$275K
|
|
|
May 15, 2023
Q1 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-114K- 75.77% |
$323K - $1.6M
|
36.5K
$241K
|
|
|
May 15, 2023
Q1 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-161K- 91.3% |
$455K - $2.25M
|
15.3K
$101K
|
|
|
May 10, 2023
Q1 2023
|
Alphabet Inc.
Mountain View, CA |
SELL
|
- |
-241K- 94.42% |
$683K - $3.37M
|
14.3K
$94.4K
|
|
|
May 15, 2023
Q1 2023
|
Nantahala Capital Management, LLC
New Canaan, CT |
SELL
|
- |
-479K- 95.73% |
$1.35M - $6.7M
|
21.4K
$141K
|
|
|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-607K- 74.34% |
$1.72M - $8.49M
|
209K
$1.39M
|